The nurse is monitoring a patient who has been receiving aldesleukin (IL-2) (Proleukin) for treatment of malignant melanoma. Which adverse effect, if noted on assessment, is of primary concern? a. Diarrhea b. Fatigue c. Nausea d. Fluid retention
[Verified Answer]: The nurse is monitoring a patient who has…
Need help with your General Clinical Pharmacology case study or NCLEX preparation? Connect with a verified Nursing expert now.